Chinese english Germany Japanese Korea

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Struktur
77368-60-6
CAS-Nr.
77368-60-6
Englisch Name:
2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid
Synonyma:
Brn 5212470;Nikkomycin I;L-Glutamic acid, (3S,4S)-4-(5-hydroxy-2-pyridinyl)-3-methyl-L-homoseryl-(6R)-2-amino-3,6-anhydro-2-deoxy-6-C-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)-L-allonoyl-;2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid;N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl]-L-glycyl]-L-glutamic acid;L-Glutamic acid, N-(L-2-(5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl)-((3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyrimidinyl)-L-valyl)glycyl)-, (2R-(2-alpha,3-beta,4-beta,5-alpha))-
CBNumber:
CB81256400
Summenformel:
C25H32N6O13
Molgewicht:
624.55
MOL-Datei:
77368-60-6.mol
Request For Quotation

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Eigenschaften

Dichte
1.666±0.06 g/cm3(Predicted)
pka
3.06±0.10(Predicted)

Sicherheit

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 19892 58
  • 2-[[2-[[2-amino-4-hydroxy-4-(5-hydroxypyridin-2-yl)-3-methyl-butanoyl] amino]-2-[5-(4-formyl-2-oxo-3H-imidazol-1-yl)-3,4-dihydroxy-oxolan-2-y l]acetyl]amino]pentanedioic acid
  • N-[2-[(2R)-5α-(4-Formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3β,4β-dihydroxyfuran-2α-yl]-N-[(3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyridinyl)-L-valyl]-L-glycyl]-L-glutamic acid
  • Nikkomycin I
  • Brn 5212470
  • L-Glutamic acid, N-(L-2-(5-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)tetrahydro-3,4-dihydroxy-2-furanyl)-((3S,4S)-4-hydroxy-4-(5-hydroxy-2-pyrimidinyl)-L-valyl)glycyl)-, (2R-(2-alpha,3-beta,4-beta,5-alpha))-
  • L-Glutamic acid, (3S,4S)-4-(5-hydroxy-2-pyridinyl)-3-methyl-L-homoseryl-(6R)-2-amino-3,6-anhydro-2-deoxy-6-C-(4-formyl-2,3-dihydro-2-oxo-1H-imidazol-1-yl)-L-allonoyl-
  • 77368-60-6
  • C25H32N6O13
Copyright 2019 © ChemicalBook. All rights reserved